Caribou Biosciences Inc
NASDAQ:CRBU
Caribou Biosciences Inc
NASDAQ:CRBU
Price:
1.99
USD
2.05%
Market Cap:
$186m
Income Statement
Earnings Waterfall
Caribou Biosciences Inc
Caribou Biosciences Inc
Income Statement
Caribou Biosciences Inc
Caribou Biosciences Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
12
N/A
|
12
-1%
|
5
-57%
|
8
+53%
|
10
+20%
|
11
+11%
|
13
+25%
|
13
-5%
|
14
+9%
|
15
+6%
|
14
-3%
|
35
+143%
|
34
0%
|
33
-3%
|
33
-1%
|
11
-65%
|
10
-13%
|
10
-1%
|
9
-8%
|
9
+2%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(48)
|
(51)
|
(58)
|
(71)
|
(77)
|
(85)
|
(102)
|
(109)
|
(120)
|
(131)
|
(135)
|
(144)
|
(151)
|
(164)
|
(175)
|
(177)
|
(177)
|
(173)
|
(165)
|
(156)
|
|
| Selling, General & Administrative |
(14)
|
(15)
|
(17)
|
(21)
|
(24)
|
(29)
|
(34)
|
(37)
|
(38)
|
(37)
|
(37)
|
(37)
|
(38)
|
(44)
|
(46)
|
(46)
|
(46)
|
(42)
|
(40)
|
(40)
|
|
| Research & Development |
(34)
|
(36)
|
(41)
|
(50)
|
(52)
|
(57)
|
(67)
|
(72)
|
(82)
|
(94)
|
(98)
|
(107)
|
(112)
|
(120)
|
(129)
|
(131)
|
(130)
|
(132)
|
(124)
|
(116)
|
|
| Operating Income |
(36)
N/A
|
(39)
-8%
|
(53)
-35%
|
(63)
-20%
|
(67)
-6%
|
(74)
-11%
|
(88)
-19%
|
(96)
-9%
|
(106)
-11%
|
(117)
-10%
|
(121)
-4%
|
(109)
+10%
|
(116)
-6%
|
(131)
-13%
|
(142)
-8%
|
(165)
-17%
|
(167)
-1%
|
(164)
+2%
|
(155)
+5%
|
(147)
+6%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
(21)
|
|
| Total Other Income |
1
|
1
|
0
|
(2)
|
(1)
|
1
|
3
|
5
|
7
|
8
|
10
|
15
|
14
|
16
|
18
|
17
|
18
|
16
|
13
|
11
|
|
| Pre-Tax Income |
(36)
N/A
|
(38)
-6%
|
(51)
-32%
|
(64)
-25%
|
(67)
-5%
|
(73)
-9%
|
(85)
-17%
|
(91)
-7%
|
(99)
-10%
|
(108)
-9%
|
(111)
-3%
|
(94)
+15%
|
(102)
-8%
|
(115)
-13%
|
(123)
-7%
|
(148)
-20%
|
(149)
-1%
|
(148)
+1%
|
(164)
-11%
|
(157)
+4%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
2
|
1
|
1
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(34)
|
(38)
|
(50)
|
(63)
|
(67)
|
(73)
|
(85)
|
(91)
|
(99)
|
(108)
|
(111)
|
(95)
|
(102)
|
(115)
|
(123)
|
(148)
|
(149)
|
(148)
|
(164)
|
(157)
|
|
| Net Income (Common) |
(34)
N/A
|
(38)
-10%
|
(50)
-33%
|
(63)
-26%
|
(67)
-6%
|
(73)
-9%
|
(85)
-17%
|
(91)
-7%
|
(99)
-9%
|
(108)
-9%
|
(111)
-3%
|
(95)
+15%
|
(102)
-8%
|
(115)
-13%
|
(123)
-7%
|
(148)
-20%
|
(149)
-1%
|
(148)
+1%
|
(164)
-11%
|
(157)
+4%
|
|
| EPS (Diluted) |
-0.6
N/A
|
-0.66
-10%
|
-0.83
-26%
|
-1.05
-27%
|
-1.11
-6%
|
-1.22
-10%
|
-1.42
-16%
|
-1.51
-6%
|
-1.64
-9%
|
-1.78
-9%
|
-1.82
-2%
|
-1.12
+38%
|
-1.38
-23%
|
-1.29
+7%
|
-1.36
-5%
|
-1.65
-21%
|
-1.65
N/A
|
-1.59
+4%
|
-1.76
-11%
|
-1.7
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
